FDA approves new therapy for people living with skin-discoloration disorder Vitiligo
(NEW YORK) -- The U.S. Food and Drug Administration granted approval on Monday for Opzelura, which is the first topical JAK inhibitor cream for the treatment of vitiligo for people 12 and older.Vitiligo, which research estimates that 1.9-2.8 million adults in the U.S. have,... Read More.
